share_log
Breakings ·  Jul 18 20:30
Neurocrine Biosciences Launches Ingrezza® Sprinkle (Valbenazine) Capsules to Ease Administration for Patients Experiencing Dysphagia or Difficulty Swallowing
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment